ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR218/004/SRR2188664/SRR2188664_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR218/003/SRR2188663/SRR2188663_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR218/006/SRR2188666/SRR2188666_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR218/004/SRR2188664/SRR2188664_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR218/005/SRR2188665/SRR2188665_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR218/003/SRR2188663/SRR2188663_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR218/005/SRR2188665/SRR2188665_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR218/006/SRR2188666/SRR2188666_2.fastq.gzprimaryOK200GenomicsMayo Clinichttps://www.ebi.ac.uk/ena/browser/view/PRJNA294117Homo sapiensWe report that RBBP4 has dual effect on gene regulation, whereby some genes are downregulated (~60%) while others are activated (~40%). Overall design: Examination of chromatin landscape of H3K9Ac in T98G cells expressing control NTshRNA compared with RBBP4 shRNA.ENAfalseHomo sapiensEpigenome screening for genes regulated by retinoblastoma-binding protein 4 (RBBP4) in glioblastoma (GBM) cells2025-09-242016-10-10PRJNA294117GSE724769606